- Home
- XLO vs ANEB Comparison
XLO vs ANEB Comparison
Compare XLO & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XLO
- ANEB
- Stock Information
- Founded
- XLO 2016
- ANEB 2020
- Country
- XLO United States
- ANEB United States
- Employees
- XLO N/A
- ANEB N/A
- Industry
- XLO Biotechnology: Pharmaceutical Preparations
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- XLO Health Care
- ANEB Health Care
- Exchange
- XLO Nasdaq
- ANEB Nasdaq
- Market Cap
- XLO 42.1M
- ANEB 36.7M
- IPO Year
- XLO 2021
- ANEB 2021
- Fundamental
- Price
- XLO $0.83
- ANEB $1.58
- Analyst Decision
- XLO Buy
- ANEB Buy
- Analyst Count
- XLO 1
- ANEB 1
- Target Price
- XLO $4.00
- ANEB $8.00
- AVG Volume (30 Days)
- XLO 592.2K
- ANEB 60.6K
- Earning Date
- XLO 11-07-2024
- ANEB 02-11-2025
- Dividend Yield
- XLO N/A
- ANEB N/A
- EPS Growth
- XLO N/A
- ANEB N/A
- EPS
- XLO N/A
- ANEB N/A
- Revenue
- XLO $4,620,000.00
- ANEB N/A
- Revenue This Year
- XLO N/A
- ANEB N/A
- Revenue Next Year
- XLO $368.76
- ANEB N/A
- P/E Ratio
- XLO N/A
- ANEB N/A
- Revenue Growth
- XLO N/A
- ANEB N/A
- 52 Week Low
- XLO $0.50
- ANEB $0.80
- 52 Week High
- XLO $1.93
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- XLO 39.23
- ANEB 51.06
- Support Level
- XLO $0.78
- ANEB $1.52
- Resistance Level
- XLO $1.28
- ANEB $1.69
- Average True Range (ATR)
- XLO 0.13
- ANEB 0.13
- MACD
- XLO -0.02
- ANEB 0.00
- Stochastic Oscillator
- XLO 9.94
- ANEB 52.00
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.